Ushbu ish iqtibos qilgan ishlar

292 ta ish

Ish: CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment

1. Stem cells and common biomaterials in dentistry: a review study

   Seyed Ali Mosaddad, Boshra Rasoolzade, Reza Abdollahi Namanloo +2

   Sharh maqola20228 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.072225

2. Pan-cancer analysis and experiments with cell lines reveal that the slightly elevated expression of DLGAP5 is involved in clear cell renal cell carcinoma progression

   Yun Feng, Fang Li, Jing Yan +15

   Maqola20215 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.047800

3. Global stabilization of the full attraction-repulsion Keller-Segel system

   Hai‐Yang Jin, Zhi‐An Wang

   Maqola20193 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.044581

4. Survivin; a novel therapeutic target that correlates with survival of autoreactive T lymphocytes obtained from patients with ankylosing spondylitis

   Navid Shomali, Behzad Baradaran, Amin Daei Sorkhabi +12

   Maqola20223 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.047821

5. VEGF as a Key Mediator of Angiogenesis in Cancer

   Peter Carmeliet

   Sharh maqola20053 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.071979

6. Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells

   M.-s. Jung, Jin Kyung Rho, Y-M Kim +7

   Maqola20122 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.002942

7. Tempol effect on epithelial-mesenchymal transition induced by hyperglycemia

   Mohammad Jafari, Farahnaz Dadras, Hamid Reza Ghadimipour +2

   Maqola20162 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.047702

8. Epithelial and endothelial mesenchymal transition and their role in diabetic kidney disease

   Farahnaz Dadras, Vida Sheikh, Farhad Khoshjou

   Maqola20172 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.047724

9. RSL3 Drives Ferroptosis Through GPX4 Inactivation and ROS Production in Colorectal Cancer

   Xinbing Sui, Ruonan Zhang, Shuiping Liu +8

   Maqola20182 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.047735

10. Factors associated with delayed diagnosis of breast cancer; a study in North-West of Iran

    Nasrin Fouladi, Maedeh Barahman, Firouz Amani +2

    Maqola20192 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.047765

11. The emerging molecular mechanism of m6A modulators in tumorigenesis and cancer progression

    Shuiping Liu, Qiujie Li, Ke Chen +7

    Sharh maqola20202 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.047769

12. <p>Nanoparticle Drug Delivery System for Glioma and Its Efficacy Improvement Strategies: A Comprehensive Review</p>

    Jie Li, Jiaqian Zhao, Tiantian Tan +7

    Sharh maqola20202 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.047770

13. Efficient isolation and identification of primary endothelial cells from bovine aorta by collagenase P

    Faezeh Seif, Alireza Kheirollah, Hossein Babaahmadi‐Rezaei

    Maqola20202 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.047774

14. Relation between Immune cell response and stemness genes expression in breast cancer; A new approach in NANOG gene and Let7-a expression in breast cancer cell lines

    Zeynab Aliyari-Serej, Ayyub Ebrahımı, Tohid Kazemi +4

    Maqola20202 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.047776

15. Dual inhibitors of histone deacetylases and other cancer-related targets: A pharmacological perspective

    Yuan Gao, Hang Zhang, Frédéric Lirussi +3

    Sharh maqola20202 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.047779

16. Small molecule DNA-PK inhibitors as potential cancer therapy: a patent review (2010–present)

    Suwen Hu, Zi Hui, Frédéric Lirussi +3

    Sharh maqola20202 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.047783

17. MgFe‐LDH Nanoparticles: A Promising Leukemia Inhibitory Factor Replacement for Self‐Renewal and Pluripotency Maintenance in Cultured Mouse Embryonic Stem Cells

    Xiaolie He, Yanjing Zhu, Li Yang +6

    Maqola20212 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.047786

18. Prognostic implication of PD-L1 expression and associated tumor infiltrating lymphocytes in metastatic breast cancer

    Mohamed M Darwish, Atef Youssef Riad, Dina Salem +3

    Maqola20212 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.047798

19. Lung cancer risk and the inhibitors of angiotensin converting enzyme; an updated review on recent evidence

    Maryam Khosravian, Mahnaz Momenzadeh, Farzad Koosha +2

    Maqola20212 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.047799

20. The regulatory role of autophagy-related miRNAs in lung cancer drug resistance

    Mahshid Shahverdi, Khalil Hajiasgharzadeh, Amin Daei Sorkhabi +9

    Sharh maqola20222 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.047809

21. RETRACTED: Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies

    Navid Shomali, Marwah Suliman Maashi, Behzad Baradaran +7

    Sharh maqola20222 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.047810

22. The Basis and Advances in Clinical Application of Cytomegalovirus-Specific Cytotoxic T Cell Immunotherapy for Glioblastoma Multiforme

    Amin Daei Sorkhabi, Aila Sarkesh, Hossein Saeedi +5

    Sharh maqola20222 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.047812

23. Cancer combination therapies by silencing of CTLA‐4, PD‐L1, and TIM3 in osteosarcoma

    Amin Daei Sorkhabi, Aila Sarkesh, Ali Fotouhi +2

    Maqola20222 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.047818

24. Evaluation of the urine mRNA-PCA3 expression level in prostate patients; comparison between benign prostatic hyperplasia and cancer

    Amid Yazdani, Farshad Namdari, Sattar Gorgani‐Firuzjaee +1

    Maqola20222 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.047819

25. Survival rates and prognostic factors of thyroid cancer: A retrospective cohort study

    Ali Amri, Ali Reza Soltanian, Shiva Borzouei

    Maqola20222 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.047824